A significant loss of bone mineral density and the appearance of multiple vertebral fractures after discontinuation of denosumab treatment have been described. To date, no hip fractures have been reported. We present three cases of patients who suffered femoral fractures after denosumab suppression.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164306 | PMC |
http://dx.doi.org/10.1177/0141076819861027 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!